Daniel C. Beachler

2.2k total citations
46 papers, 997 citations indexed

About

Daniel C. Beachler is a scholar working on Epidemiology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Daniel C. Beachler has authored 46 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Oncology and 10 papers in Otorhinolaryngology. Recurrent topics in Daniel C. Beachler's work include Cervical Cancer and HPV Research (11 papers), Head and Neck Cancer Studies (10 papers) and Diabetes Treatment and Management (8 papers). Daniel C. Beachler is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Head and Neck Cancer Studies (10 papers) and Diabetes Treatment and Management (8 papers). Daniel C. Beachler collaborates with scholars based in United States, Germany and France. Daniel C. Beachler's co-authors include Gypsyamber DʼSouza, Maura L. Gillison, Aimée R. Kreimer, Elizabeth A. Sugar, Howard D. Strickler, Kathleen M. Weber, Howard Minkoff, Dorothy J. Wiley, Ross Cranston and Susheel Reddy and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and JNCI Journal of the National Cancer Institute.

In The Last Decade

Daniel C. Beachler

42 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel C. Beachler United States 15 576 422 280 263 134 46 997
Zhen-yue Tong United States 6 718 1.2× 842 2.0× 340 1.2× 214 0.8× 58 0.4× 8 1.2k
Silvia Jiménez United States 17 1.1k 1.9× 316 0.7× 575 2.1× 263 1.0× 32 0.2× 39 1.6k
Cathy Ndiaye United States 7 430 0.7× 418 1.0× 242 0.9× 177 0.7× 15 0.1× 12 796
Elizabeth A. Van Dyne United States 9 377 0.7× 134 0.3× 182 0.7× 199 0.8× 128 1.0× 14 726
Velia Ramírez‐Amador Mexico 23 281 0.5× 304 0.7× 146 0.5× 285 1.1× 406 3.0× 56 1.3k
Louise Laporte Canada 8 335 0.6× 394 0.9× 233 0.8× 196 0.7× 14 0.1× 19 741
Barbara Winkler United States 20 901 1.6× 166 0.4× 677 2.4× 343 1.3× 32 0.2× 38 1.5k
Robert K. L. Pickard United States 15 1.1k 1.8× 1.6k 3.9× 709 2.5× 512 1.9× 91 0.7× 20 2.3k
Sara Tous Spain 19 1.2k 2.0× 183 0.4× 707 2.5× 240 0.9× 24 0.2× 47 1.5k
Christopher Maden United States 9 790 1.4× 98 0.2× 882 3.1× 281 1.1× 74 0.6× 10 1.3k

Countries citing papers authored by Daniel C. Beachler

Since Specialization
Citations

This map shows the geographic impact of Daniel C. Beachler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Beachler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Beachler more than expected).

Fields of papers citing papers by Daniel C. Beachler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Beachler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Beachler. The network helps show where Daniel C. Beachler may publish in the future.

Co-authorship network of co-authors of Daniel C. Beachler

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Beachler. A scholar is included among the top collaborators of Daniel C. Beachler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Beachler. Daniel C. Beachler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Barron, John J., Vincent J. Willey, Ozgur Tunceli, et al.. (2025). The Healthcare Integrated Research Database (HIRD) as a Real‐World Data Source for Pharmacoepidemiologic Research. Pharmacoepidemiology and Drug Safety. 34(2). e70110–e70110. 2 indexed citations
3.
4.
Anthony, Mary S., Vanita R. Aroda, Lauren E. Parlett, et al.. (2024). Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study. Diabetes Care. 47(4). 712–719. 4 indexed citations
5.
Anthony, Mary S., Daniel C. Beachler, Vanita R. Aroda, et al.. (2023). 846-P: Risk of Anaphylaxis among New Users of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs). Diabetes. 72(Supplement_1). 1 indexed citations
6.
Hoffman, Sarah R., Kimberly Daniels, Ryan Seals, et al.. (2023). Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study. Menopause The Journal of The North American Menopause Society. 30(8). 824–830. 6 indexed citations
7.
Lanes, Stephan & Daniel C. Beachler. (2023). Validation to correct for outcome misclassification bias. Pharmacoepidemiology and Drug Safety. 32(6). 700–703. 5 indexed citations
8.
Danysh, Heather E., Catherine B. Johannes, Daniel C. Beachler, et al.. (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 175–193. 2 indexed citations
9.
Johannes, Catherine B., Daniel C. Beachler, J. Bradley Layton, et al.. (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 157–174. 5 indexed citations
10.
Beachler, Daniel C., Devon H. Taylor, Mary S. Anthony, et al.. (2021). Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data. Pharmacoepidemiology and Drug Safety. 30(7). 918–926. 5 indexed citations
11.
Beachler, Daniel C., Cynthia de Luise, Devon H. Taylor, et al.. (2021). Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study. BMC Cancer. 21(1). 97–97. 19 indexed citations
12.
Beachler, Daniel C., François-Xavier Lamy, Leo Russo, et al.. (2020). A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer. Journal of Ovarian Research. 13(1). 101–101. 12 indexed citations
13.
Esposito, Daina B., Lina Titievsky, Daniel C. Beachler, et al.. (2018). Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population. Vaccine. 36(52). 8084–8093. 9 indexed citations
14.
Beachler, Daniel C., Elizabeth L. Yanik, Brook I. Martin, et al.. (2016). Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis. Journal of Bone and Joint Surgery. 98(13). 1064–1072. 31 indexed citations
15.
Beachler, Daniel C., Joseph E. Tota, Michelle I. Silver, et al.. (2016). Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. 144(2). 391–395. 13 indexed citations
16.
Beachler, Daniel C., Felisa A. Gonzales, Sarah C. Kobrin, & Aimée R. Kreimer. (2015). HPV vaccination initiation after the routine-recommended ages of 11–12 in the United States. Papillomavirus Research. 2. 11–16. 12 indexed citations
17.
Beachler, Daniel C., Yingshi Guo, Robert D. Burk, et al.. (2015). High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection. The Journal of Infectious Diseases. 212(10). 1588–1591. 14 indexed citations
18.
Beachler, Daniel C., et al.. (2013). Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women. The Journal of Infectious Diseases. 208(2). 330–339. 80 indexed citations
19.
Beachler, Daniel C., Kathleen M. Weber, Joseph B. Margolick, et al.. (2012). Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults. Cancer Epidemiology Biomarkers & Prevention. 21(1). 122–133. 168 indexed citations
20.
Beachler, Daniel C., Lisa P. Jacobson, Richard F. Ambinder, et al.. (2010). Kaposi Sarcoma-Associated Herpesvirus Serum DNA and Antibodies Not Associated With Subsequent Non-Hodgkin Lymphoma Risk. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(2). 188–192. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhen-yue Tong Breakdown of academic impact, for papers by Silvia Jiménez Breakdown of academic impact, for papers by Cathy Ndiaye Breakdown of academic impact, for papers by Elizabeth A. Van Dyne Breakdown of academic impact, for papers by Velia Ramírez‐Amador Breakdown of academic impact, for papers by Louise Laporte Breakdown of academic impact, for papers by Barbara Winkler Breakdown of academic impact, for papers by Robert K. L. Pickard Breakdown of academic impact, for papers by Sara Tous Breakdown of academic impact, for papers by Christopher Maden
Rankless by CCL
2026